FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281847415> ?p ?o ?g. }

• W4281847415 abstract "Platinum based agents-cisplatin and carboplatin in combination with taxanes are used for the treatment of ovarian cancer (OC) patients. However, the majority of OC patients develop recurrent, platinum resistant disease that is uniformly fatal. Platinum treatment enriches for chemoresistant aldehyde dehydrogenase (ALDH) + ovarian cancer stem cells (OCSCs), which contribute to tumor recurrence and disease relapse. Acquired platinum resistance also includes metabolic reprograming and switching to oxidative phosphorylation (OXPHOS). Chemosensitive cells rely on glycolysis while chemoresistant cells have the ability to switch between glycolysis and OXPHOS, depending on which pathway drives a selective advantage for growth and chemoresistance. High expression of genes involved in OXPHOS and high production of mitochondrial ROS are characteristics of OCSCs, suggesting that OCSCs favor OXPHOS over glycolysis. Based on connections between OCSCs, chemoresistance and OXPHOS, we hypothesize that platinum treatment induces changes in metabolism that contribute to platinum-induced enrichment of OCSCs.The effect of cisplatin on mitochondrial activity was assessed by JC1 staining and expression of OXPHOS genes by RT-qPCR. Cisplatin-induced changes in Sirtuin 1 (SIRT1) levels and activity were assessed by western blot. Small molecule inhibitors of mitochondrial complex I and SIRT1 were used to determine if their enzymatic activity contributes to the platinum-induced enrichment of OCSCs. The percentage of ALDH + OCSCs in OC cells and tumor tissue from xenograft models across different treatment conditions was analyzed using ALDEFLUOR assay and flow cytometry.We demonstrate that platinum treatment increases mitochondrial activity. Combined treatment of platinum agents and OXPHOS inhibitors blocks the platinum-induced enrichment of ALDH + OCSCs in vitro and in vivo. Furthermore, platinum treatment increases SIRT1 levels and subsequent deacetylase activity, which likely contributes to the increase in platinum-induced mitochondrial activity.These findings on metabolic pathways altered by platinum-based chemotherapy have uncovered key targets that can be exploited therapeutically to block the platinum-induced enrichment of OCSCs, ultimately improving the survival of OC patients." @default.
• W4281847415 created "2022-06-13" @default.
• W4281847415 creator A5009911913 @default.
• W4281847415 creator A5025953136 @default.
• W4281847415 creator A5060413058 @default.
• W4281847415 creator A5061888144 @default.
• W4281847415 creator A5062350477 @default.
• W4281847415 creator A5071622303 @default.
• W4281847415 creator A5071944785 @default.
• W4281847415 creator A5079525252 @default.
• W4281847415 creator A5087545689 @default.
• W4281847415 date "2022-05-31" @default.
• W4281847415 modified "2023-09-30" @default.
• W4281847415 title "Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer" @default.
• W4281847415 cites W1573780709 @default.
• W4281847415 cites W1954028132 @default.
• W4281847415 cites W1966354133 @default.
• W4281847415 cites W1972645332 @default.
• W4281847415 cites W1989276271 @default.
• W4281847415 cites W2001643681 @default.
• W4281847415 cites W2010559315 @default.
• W4281847415 cites W2015831734 @default.
• W4281847415 cites W2017975901 @default.
• W4281847415 cites W2020681708 @default.
• W4281847415 cites W2023300506 @default.
• W4281847415 cites W2026862874 @default.
• W4281847415 cites W2028378804 @default.
• W4281847415 cites W2036547072 @default.
• W4281847415 cites W2043658854 @default.
• W4281847415 cites W2046275490 @default.
• W4281847415 cites W2050946558 @default.
• W4281847415 cites W2058977958 @default.
• W4281847415 cites W2075394689 @default.
• W4281847415 cites W2075711878 @default.
• W4281847415 cites W2087793237 @default.
• W4281847415 cites W2094807579 @default.
• W4281847415 cites W2097948853 @default.
• W4281847415 cites W2098902167 @default.
• W4281847415 cites W2104035332 @default.
• W4281847415 cites W2111836054 @default.
• W4281847415 cites W2114843025 @default.
• W4281847415 cites W2123696077 @default.
• W4281847415 cites W2126712477 @default.
• W4281847415 cites W2130503166 @default.
• W4281847415 cites W2135846760 @default.
• W4281847415 cites W2138610504 @default.
• W4281847415 cites W2138784667 @default.
• W4281847415 cites W2140406095 @default.
• W4281847415 cites W2149441684 @default.
• W4281847415 cites W2154802086 @default.
• W4281847415 cites W2164577519 @default.
• W4281847415 cites W2340669800 @default.
• W4281847415 cites W2343016248 @default.
• W4281847415 cites W2396007914 @default.
• W4281847415 cites W2398889007 @default.
• W4281847415 cites W2401291964 @default.
• W4281847415 cites W2480701760 @default.
• W4281847415 cites W2602859993 @default.
• W4281847415 cites W2747758951 @default.
• W4281847415 cites W2756208820 @default.
• W4281847415 cites W2791235391 @default.
• W4281847415 cites W2792778724 @default.
• W4281847415 cites W2801000404 @default.
• W4281847415 cites W2806128074 @default.
• W4281847415 cites W2807649309 @default.
• W4281847415 cites W2811004693 @default.
• W4281847415 cites W2891597765 @default.
• W4281847415 cites W2902849689 @default.
• W4281847415 cites W2904380187 @default.
• W4281847415 cites W2908296170 @default.
• W4281847415 cites W2949229333 @default.
• W4281847415 cites W2983341556 @default.
• W4281847415 cites W2995771616 @default.
• W4281847415 cites W3015218076 @default.
• W4281847415 cites W3024628788 @default.
• W4281847415 cites W3043175356 @default.
• W4281847415 cites W3049198133 @default.
• W4281847415 cites W3101779884 @default.
• W4281847415 cites W3139515551 @default.
• W4281847415 cites W3152920690 @default.
• W4281847415 cites W3171622480 @default.
• W4281847415 cites W4237247596 @default.
• W4281847415 doi "https://doi.org/10.1186/s12967-022-03447-y" @default.
• W4281847415 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35641987" @default.
• W4281847415 hasPublicationYear "2022" @default.
• W4281847415 type Work @default.
• W4281847415 citedByCount "21" @default.
• W4281847415 countsByYear W42818474152022 @default.
• W4281847415 countsByYear W42818474152023 @default.
• W4281847415 crossrefType "journal-article" @default.
• W4281847415 hasAuthorship W4281847415A5009911913 @default.
• W4281847415 hasAuthorship W4281847415A5025953136 @default.
• W4281847415 hasAuthorship W4281847415A5060413058 @default.
• W4281847415 hasAuthorship W4281847415A5061888144 @default.
• W4281847415 hasAuthorship W4281847415A5062350477 @default.
• W4281847415 hasAuthorship W4281847415A5071622303 @default.
• W4281847415 hasAuthorship W4281847415A5071944785 @default.
• W4281847415 hasAuthorship W4281847415A5079525252 @default.
• W4281847415 hasAuthorship W4281847415A5087545689 @default.
• W4281847415 hasBestOaLocation W42818474151 @default.

• next